[
Brugada, J., Katritsis, D. G., Arbelo, E., Arribas, F., Bax, J. J., Blomström-Lundqvist, C., Calkins, H., Corrado, D., Deftereos, S. G., Diller, G.-P., et al. (2020). ESC Scientific Document Group, 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J., 41 (5), 655–720. doi.org/10.1093/eurheartj/ehz467.
]Search in Google Scholar
[
Chazov, E. I., Golicin, S. P. (eds.) (2010). Guide to cardiac arrhythmias [Чазов, E. И., Голицин, С. П. (ред.) Руководство no нарушению ритма сердца]. ГЭОТАР [GEOTAR], Moscow. 416 pp. (in Russian).
]Search in Google Scholar
[
De Vos, C. B, Breithardt, G., Camm, A. J., Dorian, P., Kowey, P. R., Le Heuzey, J. Y., Naditch-Brūlé, L., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C., et al. (2012). Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: Clinical correlates and the effect of rhythm-control therapy. Amer. Heart J., 163 (5), 887–893. DOI: 10.1016/j.ahj.2012.02.015.
]Open DOISearch in Google Scholar
[
Harrison, D. C. (1985). Antiarrhythmic drug classification: New science and practical applications. Amer. J. Cardiol., 56, 185–187. DOI: 10.1016/0002-9149(85)90591-0
]Open DOISearch in Google Scholar
[
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J., 42 (5), 373–498. doi.org/10.1093/eurheartj/ehaa612.
]Search in Google Scholar
[
Hrebenyk, M. V., Masliy, S. M. (2017). Clinical experience of pharmaco-therapy of arrhythmias: Focus on ethacizine — effectiveness and safety profile [Гребеник, M. В., Маслш, С. M. Кшшчний досвщ фармако- терапп аритмш: фокус на етацизин - ефектившсть i профшь безпечносл;]. Укр. Кард. Журнал [Ukr. Card. J.], No. 6, 96–103 (in Ukrainian)
]Search in Google Scholar
[
Kaik, J., Kaik, V., Kiitam, M. (1992). Antiarrhythmic efficacy of ethacizine assessed by programmed electrical stimulation in patients with ventricular tachycardia. Pacing Clin. Electrophysiol., 15, 2134–2137. doi.org/10.1111/j.1540-8159.1992.tb03036.x.
]Search in Google Scholar
[
Kokina, B., Strēlnieks, A., Pupkeviča, I., Jubele, K., Vikmane, M., Sakne, S., Sokolova, E., Urtāne, I., Lejnieks, A., Kalējs, O. (2021). Sinus rhythm maintenance after electrical cardioversion for atrial fibrillation in high-risk patients — comparative efficacy of antiarrhythmic medications. Proc. Latvian Acad. Sci. Section B, 75 (1), 32–39. doi.org/10.2478/prolas-2021-0006.
]Search in Google Scholar
[
Kovalenko, V. M., Lutay, M. I., Sirenko, Y. M., Sychov, O. S. (eds.) (2021). Cardiovascular Diseases. Classification, Standards of Diagnosis and Treatment [Коваленко, В.М., Лутай, M.I., Сiренко, Ю.М., Сичов, О.С. (ред). Серцево-судинш захворювання. Класифжащя, стандарти дiагносmukи та лщвання]. MOPIOH [MORION]. Kyiv, pp. 153–273 (in Ukrainian).
]Search in Google Scholar
[
Lei, M., Wu, L., Terrar, D. A, Huang, C. L-H. (2018). Modernized classification of cardiac antiarrhythmic drugs. Circulation, 138 (17), 1879–1896. DOI: 10.1161/CIRCULATIONAHA.118.035455
]Open DOISearch in Google Scholar
[
Lishnevskaja, V. Ju., Papuga, M. S. (2007). Ethacizine in the correction of ventricular arrhythmias in elderly patients with coronary heart disease [Лишневская, В. Ю., Папуга, М. С. Этацизин в коррекции желудоч-ковых нарушений ритма у больных ишемической болезнью сердца пожилого возраста]. Укр. Тер. Журнал [Ukr. Ther. J.], 7, 87–90 (in Russian).
]Search in Google Scholar
[
Moroz, V. M., Lipnitskiy, T. N. (2006). Experimental modeling of patho-genetic mechanisms of sudden death in the treatment of patients with sodium channel blockers [Мороз, В. М., Липницкий, Т. Н. Эксперимен-тальное моделирование патогенетических механизмов внезапной смерти в лечении больных блокаторами натриевых каналов]. Российский кардиол. журнал [Russian J. Cardiol.], 3, 67–70 (in Russian).
]Search in Google Scholar
[
Polyakov, A. V., Svistunov, A. A., Kondratenko, S. N., Kovachevich, I. V., Repenkova, L. G., Savelyeva, M. I., Kukes, V. G. (2020) Peculiarities of pharmacokinetics and bioavailability of some cardiovascular drugs under conditions of antiorthostatic hypokinesia. Bull. Exp. Biol. Med., 168 (4), 465–469. DOI: 10.1007/s10517-020-04732-w.
]Open DOISearch in Google Scholar
[
Singh, B. N. (1972). A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function. Cadiovasc. Res., 6, 109–119. DOI: 10.1093/cvr/6.2.109.
]Open DOISearch in Google Scholar
[
Sokolova, E., Ofrosimova, P., Rudzitis, A., Kalejs, O. (2021a). Exercise stress test in patient with persistent form of atrial fibrillation receiving treatment with Class Ic antiarrhythmic drugs after sinus rhythm restoration. In: International Research Conference on Medical and Health Care Sciences: Knowledge for use in Practice 2021. 24-26 March 2021, Rīga, Latvia. Rīga Stradiņš University, Rīga, 134. https://science.rsu.lv/en/publications/exercise-stress-test-in-patient-with-persistent-form-of-atrial-fi (accessed 16.01.2023).
]Search in Google Scholar
[
Sokolova, E., Strelnieks, A., Kokina, B., Rudzitis, A., Lejnieks, A., Kalejs, O. (2021b). Inotropic function of myocardium in patients with persistent form of atrial fibrillation receiving antiarrhythmic drugs class Ic. In: International Research Conference on Medical and Health Care Sciences: Knowledge for use in Practice 2021. 24–26 March 2021, Rīga, Latvia. Rīga Stradiņš University, Rīga, 138. https://science.rsu.lv/en/publications/inotropic-function-of-myocardium-in-patients-with-persistent-form (accessed 16 .01.2023).
]Search in Google Scholar
[
Shukla, A., Curtis, A. B. (2014) Avoiding permanent atrial fibrillation: Treatment approaches to prevent disease progression. Vasc. Health Risk Manag., 10, 1–12. DOI: 10.2147/VHRM.S49334.
]Open DOISearch in Google Scholar
[
Sychev, O. S., Romanova, E. N., Sribnaja, O. V. (2016). The results of the clinical study “Evaluation of the efficacy and safety of the drug ethacizine in patients with arrhythmias without severe organic heart disease” [Сычев, О. С., Романова, Е. Н., Срибная, О. В. Результаты клинического исследования «Оценка эффективности и безопасности препарата этацизин у больных с нарушением ритма без выраженной органической патологии сердца»]. Аритмологы [Arrhythmology], 3 (19), 2–11 (in Russian).
]Search in Google Scholar
[
Sydorova, N. M. (2021). Antiarrhythmic drug classification updates: The King's Gambit for researchers and practitioners? Analytical literature review [Сидорова, H. M. Оновлення класифжаци антиаритм1чних засоб1в: королiвский гамбiг для дослiдниkiв та пракгиkiв? Аналiтичний огляд лiератури]. Сучасш аспекти вшсъково! медицини [Current aspects of military medicine], 28 (1), 214–235. DOI.org/10.32751/2310-4910-2021-28-2-18 (in Ukrainian).
]Search in Google Scholar
[
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989). Effect of encainide and flecainide on mortality in a randomized trial of ar-rhythmia suppression after myocardial infarction. New Engl. J. Med., 321 (6), 406–412. doi: 10.1056/NEJM198908103210629.
]Open DOISearch in Google Scholar
[
The Cardiac Arrhythmia Suppression Trial II (CAST) Investigators (1992). Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. New Engl. J. Med., 327 (4), 227–233. DOI: 10.1056/NEJM199207233270403.
]Open DOISearch in Google Scholar
[
Volkov, V. I., Strona V. I. (2008). Dose-dependent and gender features of the action of ethacizine in patients with coronary artery disease with ventricular arrhythmias. [Волков, В. И., Строна, В. И. Дозозависимые и гендерные особенности действия этацизина у больных ИБС с желудочковыми нарушениями сердечного ритма]. Укр. Тер. Журнал [Ukr. Ther. Journal], 4, 36–41 (in Russian).
]Search in Google Scholar
[
Williams, V. E. M. (1970). Classification of anti-arrhythmic drugs. In: Symposium on Cardiac Arrhythmias. Sandfte, E., Flensted-Jensen, E., Olesen, K. H. (eds.). AB ASTRA, Södertälje, Sweden, pp. 449–472.
]Search in Google Scholar
[
Zeppenfeld, K., Tfelt-Hansen, J., de Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, F., Corrado, D., Dagres, N., de Chillou, C., et al. (2022). ESC Scientific Document Group, 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J., 43 (40), 3997–4126. DOI.org/10.1093/eurheartj/ehac262.
]Search in Google Scholar
